Share this article
VeChain to Develop Drug-Tracing Platform for Pharma Giant Bayer
Bayer China is tapping VeChain to help it track clinical trial drugs along the blockchain.
Updated Sep 14, 2021, 8:45 a.m. Published May 28, 2020, 2:13 p.m.
Make us preferred on Google
One of the largest pharmaceutical companies in the world is working with VeChain to develop a new blockchain-based traceability platform.
STORY CONTINUES BELOW
Bayer China revealed in an interview Thursday it had chosen VeChain as tech provider for a new blockchain-powered solution that will allow the firm – a branch of Bayer – to track clinical drugs across the supply chain.
Known as "CSecure," the system loads a batch number relating to a specific drug onto the blockchain. Each drug can then be tracked as it moves across the supply chain, using timestamps and user-identification information at different waypoints. Because of the immutable nature of the blockchain, the data can't be changed by a non-permissioned third party.
Also see: IBM, Merck Declare FDA-Backed Drug Tracing Blockchain a Success
VeChain won the right to work with Bayer China in a competition back in 2019, after it proposed the company consider implementing a blockchain-based supply chain solution. The proposal subsequently went on to become CSecure.
The system is based on ToolChain, a proprietary blockchain-as-a-service (BaaS) system that allows VeChain to design and build full distributed ledger technology solutions to a client's specific requirements.
Bayer China is the latest in a series of high-profile partnerships for the blockchain project. Last June, the Chinese arm of supermarket chain Walmart, as well as Big Four accountancy firm PwC teamed up with VeChain to work on a new food tracking solution for China.
However, VeChain isn't saying much about the latest deal. A spokesperson told CoinDesk that the firm is bound by a non-disclosure agreement (NDA) and can't divulge further information about how CSecure would actually work "under the hood."
See also: VeChain Foundation Hacked for $6.5M in VET Token Theft
A statement from CEO and co-founder Sunny Lu did say he was grateful Bayer put VeChain through its paces in testing CSecure's product design.
“We’ve experienced the rigorousness of the medical industry by working with Bayer China," he said. "I feel Bayer’s professionalism and superb work ethic towards medicine and healthcare causes as a whole."
Last year, Uganda’s president backed a similar tracking project from MediConnect that was to use blockchain tech to fight the issue of counterfeit medicines.
More For You
KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.
What to know:
- KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.
- This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.
- Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.
- Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.
- Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.
More For You
Solana’s new phase is ‘much more about finance,’ says Backpack CEO Armani Ferrante
The Solana ecosystem has spent the past year doubling down on a financial infrastructure, Backpack CEO Armani Ferrante told CoinDesk.
What to know:
- Solana’s latest phase looks a lot less flashy than its memecoin-fueled highs, and that may be the goal.
- Armani Ferrante, CEO of crypto exchange Backpack, told CoinDesk in an interview the Solana ecosystem has spent the past year doubling down on a more sober focus: financial infrastructure. A
- fter years of experimentation as the wider crypto industry focused on NFTs, games and social tokens, attention is now shifting back toward decentralized finance, trading and payments.
Top Stories
